Education:
1993 M.D. Medicine Beijing Medical University
1995 M.S. Medicine (Mentor: Dr. Yipu Chen) Beijing Medical University
2004 Ph.D. Pathology (Mentor: Dr. Gregory Dressler) University of Michigan

Post Graduate Education and Training:
1995-07 Residency Internal Medicine Beijing Medical University, First Teaching Hospital
2006-10 Residency Pathology Department of Pathology, University of Michigan
2010-11 GI Fellowship Department of Pathology, Cleveland Clinic, OH

Academic Faculty Appointment:

2022-present Professor. Department of Pathology and Laboratory Medicine. School of Medicine, Indiana University

2017-2022 Associate Professor with tenure. Department of Pathology and Laboratory Medicine. School of Medicine, Indiana University

2011-17 Assistant Professor. Department of Pathology and Laboratory Medicine. School of Medicine, Indiana University

2017-present Associate Professor with tenure. Department of Pathology and Laboratory Medicine. School of Medicine, Indiana University

2011-16 Assistant Professor. Department of Pathology and Laboratory Medicine. School of Medicine, Indiana University

The Histopathologic Features of Sickle Cell Hepatopathy: A Multi-Institutional Study.
Saeed O, Panarelli N, Umrau K, Lee H, Westerhoff M, Cheng J, Lin J.Am J Clin Pathol. 2022 Jan 6;157(1):73-81. doi: 10.1093/ajcp/aqab096.PMID: 34463318

Mucinous intrahepatic cholangiocarcinoma: a distinct variant.
Chi Z, Bhalla A, Saeed O, Cheng L, Curless K, Wang HL, Patil DT, Lin J.Hum Pathol. 2018 Aug;78:131-137. doi: 10.1016/j.humpath.2018.04.010. Epub 2018 Apr 23.PMID: 29698701

Histopathological evidence of neoplastic progression of von Meyenburg complex to intrahepatic cholangiocarcinoma.
Bhalla A, Mann SA, Chen S, Cummings OW, Lin J.Hum Pathol. 2017 Sep;67:217-224. doi: 10.1016/j.humpath.2017.08.004. Epub 2017 Aug 18.PMID: 28823571

IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.
Lin J, Cummings OW, Greenson JK, House MG, Liu X, Nalbantoglu I, Pai R, Davidson DD, Reuss SA.Scand J Gastroenterol. 2015 Apr;50(4):447-53. doi: 10.3109/00365521.2014.962603. Epub 2015 Jan 30.PMID: 25635498

Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.
Lin J, Welker NC, Zhao Z, Li Y, Zhang J, Reuss SA, Zhang X, Lee H, Liu Y, Bronner MP.Mod Pathol. 2014 Apr;27(4):602-8. doi: 10.1038/modpathol.2013.152. Epub 2013 Sep 20.PMID: 24051693

Is the presence of 6 or fewer crypt apoptotic bodies sufficient for diagnosis of graft versus host disease? A decade of experience at a single institution.
Lin J, Fan R, Zhao Z, Cummings OW, Chen S.Am J Surg Pathol. 2013 Apr;37(4):539-47. doi: 10.1097/PAS.0b013e318272c62a.PMID: 23211294

MicroRNA expression patterns in indeterminate inflammatory bowel disease.
Lin J, Cao Q, Zhang J, Li Y, Shen B, Zhao Z, Chinnaiyan AM, Bronner MP.Mod Pathol. 2013 Jan;26(1):148-54. doi: 10.1038/modpathol.2012.131. Epub 2012 Aug 17.PMID: 22899284

Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma.
Liu X, Goldblum JR, Zhao Z, Landau M, Heald B, Pai R, Lin J.Am J Surg Pathol. 2012 Aug;36(8):1228-33. doi: 10.1097/PAS.0b013e318253645a.PMID: 22790862